Sarah Cannon Research Institute at Colorado Blood Cancer Institute is a clinical research site located in Denver, Colorado, United States 80218.
Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.
Sarah Cannon Research Institute at Colorado Blood Cancer Institute has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL).
Sponsors: Syros Pharmaceuticals, Nurix Therapeutics, Inc..
Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Sarah Cannon Research Institute at Colorado Blood Cancer Institute has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Sarah Cannon Research Institute at Colorado Blood Cancer Institute has 2 clinical trials on record, with 1 currently active. Their work covers Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL).
Sarah Cannon Research Institute at Colorado Blood Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.